Autori: Moiseenko Fedor
| Naslov | Baseline Radiomics as a Prognostic Tool for Clinical Benefit from Immune Checkpoint Inhibition in Inoperable NSCLC Without Activating Mutations (Article) |
| Autori | Moiseenko Fedor Radulovic Marko ... (broj koautora 18) |
| Info | CANCERS, (2025), vol. 17 br. 11, str. - |
| Projekat | Ministry of Science, Technological Development and Innovation of the Republic of Serbia; [451-03-136/2025-03/200043] |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa |
| Naslov | Candidate Bevacizumab Biosimilar CT-P16 versus European Union Reference Bevacizumab in Patients with Metastatic or Recurrent Non-Small Cell Lung Cancer: A Randomized Controlled Trial (Article) |
| Autori | Verschraegen Claire Andric Zoran G Moiseenko Fedor Makharadze Tamta Shevnya Sergii Oleksiienko Alona Ruiz Eduardo Yanez Kim SungHyun Ahn KeumYoung Park TaeHong Park Sijin Ju Hana Ohe Yuichiro |
| Info | BIODRUGS, (2022), vol. 36 br. 6, str. 749-760 |
| Projekat | Celltrion, Inc. (Incheon, Republic of Korea) |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
